C-endo Diab Endo Clin Calgery

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes2 trials
• Obesity1 trial

Phase

• Phase 32 trials

Status

• Completed2 trials

Lead sponsor

• Novo Nordisk A/S2 trials

Closed trials

• Completed

  A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weight

  NCT05394519· Phase 3· Novo Nordisk A/S· Source

• Completed

  A Heart Disease Study of Semaglutide in Patients With Type 2 Diabetes

  NCT03914326· Phase 3· Novo Nordisk A/S· Source